health
Female Fertility Improvement
Female Fertility Improvement describes a favorable change in fertility-related outcomes for women. It is a broad outcome category rather than a single symptom or diagnosis, and may involve measures such as menstrual regularity or results connected with an IVF cycle.
A focused starting point for understanding the Female Fertility Improvement topic.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What may help
None of these options has good evidence yet. Best evidence first.
5 options:5 not enough evidence
AcupuncturepracticeNot enough evidence
Too few or too small studies to know if it works.
3 of 4 studies found a benefit; 1 found none. Strongest study: a pooled analysis of several trials.
A pooled analysis of randomized trials involving 936 people found an increase of 2.22 oocytes in one comparison. Another analysis reported
Open the Acupuncture pageTai ChipracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a randomized controlled trial.
A randomized trial of 120 people with PCOS reported a between-group difference in cycle reduction of 6.79 days.
Open the Tai Chi pageFastingpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a systematic review of studies.
A pooled analysis whose designs were not recorded reported that menstrual cycles normalized in over 70% of 30 patients.
Open the Fasting pageMindfulness MeditationpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a randomized controlled trial.
In a trial with 100 participants receiving care for female infertility, the mindfulness meditation group had higher numbers of punctured follicles and retrieved oocytes.
Open the Mindfulness Meditation pageYogapracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a non-randomized trial.
A quasi-experimental study involving 25 people with PCOS reported regular menstrual cycles and conception during or after a 12-week yoga intervention among participants with a history of infertility.
Open the Yoga page
The expert view shows every study, dose protocol and source.
What may help
Linked to improving it5 listedStart here
The best we have, but the evidence is still weak
- →PracticesAcupunctureCertaintyLowSourceRCTTrivial effect5 other sources
A pooled analysis of randomized trials involving 936 people found an increase of 2.22 oocytes in one comparison. Another analysis reported
How big is the effect
Trivial effectReal in studies, but too small for most people to notice.
Who was studied
- People with a condition
- Female Infertility
- Poor Ovarian Reserve
Open AcupunctureStudy result
TEAS was superior to EA [MD = 1.85, 95% CI = (0.86, 2.84)], MA [MD = 2.31, 95% CI = (1.43, 3.19)] and control [MD = 2.22, 95% CI = (1.59, 2.85)] in increasing the number of oocytes.
- →PracticesTai ChiCertaintyLowSourceClinical1 other source
A randomized trial of 120 people with PCOS reported a between-group difference in cycle reduction of 6.79 days (P = 0.008).
Who was studied
- People with a condition
- Pcos
Open Tai ChiStudy result
the between-group difference in cycle reduction was 6.79 days (95% CI: 0.14-1.02, P = 0.008)
- →PracticesFastingCertaintyLowSourceClinical1 other source
A pooled analysis whose designs were not recorded reported that menstrual cycles normalized in over 70% of 30 patients.
Who was studied
- People with a condition
Open FastingStudy result
menstrual cycles normalized in over 70% of patients
- →PracticesMindfulness MeditationCertaintyLowSourceClinical1 other source
In a trial with 100 participants receiving care for female infertility, the mindfulness meditation group had higher numbers of punctured follicles and retrieved oocytes.
Who was studied
- People with a condition
- Female Infertility
Open Mindfulness MeditationStudy result
the MM group had higher numbers of punctured follicles and retrieved oocytes (P<0.001)
- →PracticesYogaCertaintyLowSourceClinical1 other source
A quasi-experimental study involving 25 people with PCOS reported regular menstrual cycles and conception during or after a 12-week yoga intervention among participants with a history of infertility.
Who was studied
- People with a condition
- Pcos
Open YogaStudy result
We have observed significant improvements in clinical parameters, for instance, experiencing regular menstrual cycles, conception, reduced hirsutism... Among the 25 participants, five of the eleven married women had a history of infertility. During and after the 12-week yoga intervention, these five
Practices compared
Practices with at least one trial of their own for this goal. Ranked by how sure the evidence is, then effect size.| Practice | How sure | Effect size | Own trials |
|---|---|---|---|
| Acupuncture | CertaintyLowSourceRCT | Trivial effect | 3 trials or pooled analyses |
| Fasting | CertaintyLowSourceClinical | 1 trial or pooled analysis | |
| Mindfulness Meditation | CertaintyLowSourceClinical | 1 trial or pooled analysis | |
| Tai Chi | CertaintyLowSourceClinical | 1 trial or pooled analysis | |
| Yoga | CertaintyLowSourceClinical | 1 trial or pooled analysis |
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Female Fertility Improvement describes a favorable change in fertility-related outcomes for women. It is a broad outcome category rather than a single symptom or diagnosis, and may involve measures such as menstrual regularity or results connected with an IVF cycle. The interventions associated with this topic include options such as Coenzyme Q10, L-Carnitine, Inositol, and Resveratrol.
How interventions help
Interventions linked with female fertility improvement differ in what they measure and how quickly a change may appear. Coenzyme Q10 was studied over 60 days, while L-Carnitine was used over 4-6 months; their reported findings concern different outcomes, with L-Carnitine specifically associated with increased menstrual regularity ratings. Inositol was studied starting 1 month before an IVF cycle, making its use distinct from interventions evaluated over longer continuous periods. Meditation was associated with a higher rate of ultrasound-confirmed intrauterine pregnancy, while Yoga was evaluated during and after a 12-week intervention and included observations involving menstrual cycles, conception, and hirsutism.
Other findings focus on reproductive markers rather than pregnancy itself. Selenium was associated with increases in AMH, AFC, and MOV, whereas Melatonin was linked with increased oocyte quality in animal research. Chamomile research in animals examined follicle and corpus luteum changes after 21 days, and Ashwagandha research in animals reported increases after 21 days at several doses. These animal findings do not establish that the same effects occur in people.
The evidence therefore does not describe one uniform type of fertility intervention. Some findings involve human participants and outcomes such as pregnancy or menstrual regularity; others involve laboratory or ovarian markers, animal models, or a comparison not designated as human evidence, as with Resveratrol. The time needed before an outcome was assessed also varied substantially, and the available findings do not establish whether benefits persist after an intervention is stopped.
Choosing guidance
For readers who want evidence from human studies, Coenzyme Q10, L-Carnitine, Inositol, Meditation, and Yoga are the most relevant options to compare. The first three were studied with sustained use, while Inositol was examined in relation to an IVF cycle. Meditation and Yoga represent different kinds of evidence: Meditation comes from a controlled human study, whereas Yoga was evaluated in a small clinical-condition setting, so its findings may not generalize broadly.
The options are not directly interchangeable because the studies measured different outcomes and used different study designs. Coenzyme Q10 and L-Carnitine have evidence from reviews that combine human studies, while Inositol’s evidence is also human but more specifically tied to fertility treatment. This makes the treatment context important when deciding which findings are most applicable.
Chamomile, Ashwagandha, and Melatonin are supported here by animal research rather than human evidence. Selenium and Resveratrol likewise do not have human evidence represented here; although Resveratrol is categorized as clinical, its listed evidence is not human. These options are therefore better viewed as preliminary rather than as human-tested alternatives. The listed studies do not identify conflicting findings, but the amount and type of evidence vary substantially between options.